Spots Global Cancer Trial Database for glioma of brain
Every month we try and update this database with for glioma of brain cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors | NCT03194906 | Glioma of Brain Craniopharyngio... Ependymoma Germ Cell Tumor | Memantine Placebo Cognitive Asses... | 6 Years - 21 Years | St. Jude Children's Research Hospital | |
| Pilot Study of Mirtazapine for the Dual Tx of Depression and CINV in High-Grade Glioma Pts on TMZ | NCT03935685 | Glioma of Brain | Mirtazapine (Re... | 18 Years - | University of California, Irvine | |
| Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently | NCT03496181 | Glioma Glioma of Brain Glioma of Spina... | Multilingual Ap... Language paradi... Language paradi... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Blood Biomarker Signature in Glioma | NCT03698201 | Glioma of Brain | Non-interventio... | 18 Years - | Cancer Trials Ireland | |
| A Study Utilizing Escitalopram in Glioma Patients | NCT03728673 | Glioma of Brain Glioma | Escitalopram Or... | 19 Years - | University of Nebraska | |
| CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients | NCT04406610 | Glioma of Brain CAR-T Cell Immu... | GD2 CAR-T immun... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glioma at First Relapse | NCT03779230 | Glioma of Brain | L19TNF | 18 Years - 90 Years | Philogen S.p.A. | |
| Blood Biomarker Signature in Glioma | NCT03698201 | Glioma of Brain | Non-interventio... | 18 Years - | Cancer Trials Ireland | |
| Visual Study of Molecular Genotype in Glioma Evolution | NCT03750890 | Glioma of Brain | - | Tongji Hospital | ||
| Blood Biomarker Signature in Glioma | NCT03698201 | Glioma of Brain | Non-interventio... | 18 Years - | Cancer Trials Ireland | |
| Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glioma at First Relapse | NCT03779230 | Glioma of Brain | L19TNF | 18 Years - 90 Years | Philogen S.p.A. | |
| Expanded Access for Pembrolizumab (MK-3475) | NCT03311542 | Melanoma (Skin) Melanoma Recurr... Glioblastoma Mu... Glioblastoma by... Glioma of Brain | pembrolizumab | 18 Years - 80 Years | Center Trials & Treatment | |
| Glioma Microenvironment an Exploratory Study | NCT03189420 | Glioma of Brain | Tumor resection | 18 Years - 65 Years | Hospital Sirio-Libanes | |
| A Phase 0 /II Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection | NCT03834740 | Glioblastoma Mu... Glioma of Brain | Ribociclib Everolimus | 18 Years - | St. Joseph's Hospital and Medical Center, Phoenix | |
| A Phase 0 /II Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection | NCT03834740 | Glioblastoma Mu... Glioma of Brain | Ribociclib Everolimus | 18 Years - | St. Joseph's Hospital and Medical Center, Phoenix | |
| Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma | NCT03927274 | Glioma of Brain | Topotecan | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Early Temozolomide in Patients With High-Grade Gliomas in Rehabilitation | NCT03796507 | Glioma of Brain | Temozolomide | 18 Years - | University of Rochester | |
| The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas | NCT03180697 | Diagnoses Disea... Glioma of Brain | APT MR Imaging | 18 Years - 80 Years | Zhujiang Hospital | |
| Visual Study of Molecular Genotype in Glioma Evolution | NCT03750890 | Glioma of Brain | - | Tongji Hospital | ||
| A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 | NCT03650257 | Glioma of Brain | gp96 Temozolomide radiotherapy | 18 Years - 75 Years | Cure&Sure Biotech Co., LTD | |
| Longitudinal Analysis of the Health-related Quality of Life in Glioma Patients | NCT03849430 | Glioma of Brain | 18 Years - | Universitaire Ziekenhuizen KU Leuven | ||
| An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas | NCT03460782 | Glioblastoma Glioma of Brain | Ipilimumab | 18 Years - 80 Years | Center Trials & Treatment | |
| Seizure Prophylaxis in Patients With Glioma or Brain Metastasis | NCT03436433 | Glioma Glioma of Brain Brain Tumor | Lacosamide Levetiracetam | 18 Years - 99 Years | Duke University | |
| Expanded Access for Pembrolizumab (MK-3475) | NCT03311542 | Melanoma (Skin) Melanoma Recurr... Glioblastoma Mu... Glioblastoma by... Glioma of Brain | pembrolizumab | 18 Years - 80 Years | Center Trials & Treatment | |
| Seizure Prophylaxis in Patients With Glioma or Brain Metastasis | NCT03436433 | Glioma Glioma of Brain Brain Tumor | Lacosamide Levetiracetam | 18 Years - 99 Years | Duke University | |
| Efficacy of Kangliuwan for Recurrent Grade IV Glioma | NCT03949192 | Glioma of Brain Recurrence | 18 Years - 80 Years | Xuanwu Hospital, Beijing | ||
| Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy | NCT03534050 | Glioma of Brain | postoperative a... | 20 Years - 84 Years | Chang Gung Memorial Hospital | |
| Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors | NCT03194906 | Glioma of Brain Craniopharyngio... Ependymoma Germ Cell Tumor | Memantine Placebo Cognitive Asses... | 6 Years - 21 Years | St. Jude Children's Research Hospital | |
| A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 | NCT03650257 | Glioma of Brain | gp96 Temozolomide radiotherapy | 18 Years - 75 Years | Cure&Sure Biotech Co., LTD | |
| Efficacy of Kangliuwan for Recurrent Grade IV Glioma | NCT03949192 | Glioma of Brain Recurrence | 18 Years - 80 Years | Xuanwu Hospital, Beijing | ||
| Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma | NCT03739372 | Glioma Glioma of Brain Cancer Pediatric Cance... Pediatric Brain... Astrocytoma Glioblastoma Hemispheric | Specialized tum... | - 21 Years | University of California, San Francisco | |
| Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy | NCT03534050 | Glioma of Brain | postoperative a... | 20 Years - 84 Years | Chang Gung Memorial Hospital | |
| CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients | NCT04406610 | Glioma of Brain CAR-T Cell Immu... | GD2 CAR-T immun... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases | NCT03698162 | Brain Metastase... Glioma of Brain Brain Tumor Metastatic Mela... | Dynamic Contras... Bevacizumab Inj... | 21 Years - | University of Southern California | |
| Noninvasively Predicting Gene Status of Glioma | NCT03102112 | Glioma of Brain | MRI examination | - | Tang-Du Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
